CEACAM5 and prostate carcinoma: As shown in Figure 2, prostate carcinoma cells were significantly more sensitive to CTL-mediated lysis targeting CEA (P = 0.002), brachyury (P = 0.0004), MUC1 (P < 0.0001), or PSA (P = 0.0011).